CSL gets European OK for Novartis flu vaccines purchase; GSK's malaria vax may pick up key approval Friday;

> CSL received regulatory approval from the European Commission on its deal to buy Novartis' ($NVS) flu vaccine business, though the deal has not closed yet. Report

> European regulators could recommend GlaxoSmithKline's ($GSK) malaria vaccine--the world's first such shot--on Friday, Reuters reported. Story

> Focusing on blocking the disease's transmission process, a professor from Oklahoma University is working to develop a malaria vaccine. Report

And Finally... Portland State University virologists discovered how to neutralize viruses by coating them in silica and then bring them back to life by removing the coat--the team dubbed them "zombie viruses." Report

Suggested Articles

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.

AZ is among the companies leading the COVID-19 vaccine race, and after agreeing first to supply the U.K., it's now in talks for delivery worldwide.